Skip to main content
Premium Trial:

Request an Annual Quote

BioView, ScreenCell Partner to Develop CTC Analysis Technology

NEW YORK (GenomeWeb News) – BioView and ScreenCell today announced a deal to develop a circulating tumor cell analysis technology.

The agreement seeks to combine ScreenCell's technology for isolating rare cells that may have prognostic and predictive value in cancer and BioView's scanning platform, which provides automated imaging and analysis solutions for rare cell and circulating tumor cell detection.

ScreenCell CEO David Znaty said in a statement, "Our objective is to support a breakthrough in personalized medicine by creating a non-invasive evaluation of specific therapeutic targets and 'real time' monitoring of target evolution which we strongly believe will be facilitated by combining ScreenCell and BioView technologies."

BioView is based in Rehovot, Israel and its Imaging Systems use field-proven algorithms and accommodate "both the need for CTC enumeration and retrieval of cellular and marker characteristics of captured cells," the company said.

Paris-based ScreenView's technologies isolate tumor cells by size and characterize them. The devices can be used for mesenchymal cells, cancer stem cells, microemboli, and cancer cells of non-epithelial origin.

Terms of the deal were not disclosed.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.